Echo Therapeutics Waiting to Hear Back from FDA
On November 11th of this year, Echo Therapeutics Inc™, a transdermal medical device company based out of Franklin, Massachussetts, submitted their revolutionary Prelude SkinPrep System™ […]
Articles by Guy M. Scrivo
Vicor Technologies Inc™ Changes Board of Directors
Vicor Technologies™, a biotechnology company based out of Boca Raton, recently announced a change in their Board of Directors. On November 16th of this year, […]
Diabetes, Oncology, Drug Delivery
MannKind is a biopharmaceutical company that actualizes therapeutics for the treatment of diabetes and cancer, and has also developed a novel inhalation-based drug delivery system that enables enhanced…
Infectious Diseases
Inhibitex is a specialty biopharmaceutical company that focuses on the production of therapeutics to treat infectious diseases, specifically the viral infections Shingles and Hepatitis C, as well as Staph bacterial infections, which include…
Oncology, Pain Management
Infinity Pharmaceuticals is a biopharmaceutical company that has developed a targeted drug development platform to actualize small molecule inhibitors against specific bioactive proteins that play critical roles in biological…
Wound Care Market Prepared to Take a Beating
Wound care has come a long way since the days of biting the bullet and gauze bandages. Recent advancements in the treatment of wounds and […]
Cardiogenesis Breaks Ground on Heart-Pumping New Research
Cardiogenesis, the clinical and market leader in transmyocardial revascularization (TMR), revealed this week that it has enrolled its first two patients for its feasibility study involving the cutting-edge PHOENIX System.
Pressure BioSciences Presents Symposium On Applications of PCT Technology
On May 21, 2010 Pressure BioSciences, Inc. (NasdaqCM: PBIO) sponsored a symposium at Harvard Medical School on the “Applications of Ultra-High Pressure in Technology.”
Urovalve Granted IDE Approval for Bladder Management System
The Surinate Bladder Management system is comprised of a simple magnetically controlled valve that can be activated remotely by a Surinate wearer who uses a hand held magnet to self-regulate flow.
Urovalve at the 2010 OneMedForum
Harvey Homan, President and CEO of Urovalve, discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.